Deep search
Search
Images
Videos
Maps
News
Shopping
Copilot
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past hour
Any time
Past 24 hours
Past 7 days
Past 30 days
Most recent
Best match
13m
Why a common asthma drug will now carry extra safety warnings about depression
The TGA has issued a requirement for new warnings to be provided with the drug montelukast, commonly used to treat asthma and ...
DublinLive
43m
Dublin City Council introducing 'light boxes' to help combat Seasonal Affective Disorder
The devices have been proven to lift people’s moods, boost alertness and help those who use them feel more energised ...
Hosted on MSN
51m
FDA Clears Spravato For Monotherapy Depression Treatments
The Food and Drug Administration has approved Johnson & Johnson's nasal spray as a standalone treatment for severe forms of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Los Angeles wildfire updates
California fires: How to help
Waltz resigns from House
Coast Guard chief fired
Silk Road founder pardoned
Released from prison
'Days of Our Lives' star dies
SCOTUS grants new hearing
Raising prices again
FDA approves nasal spray
Agent fatally shot in VT
Set to leave DOGE
Taliban frees 2 Americans
Milley's portrait taken down
NC Rep. Joe John resigns
Israel’s top general resigns
Former prosecutor faces trial
Fire at ski resort in Turkey
Gulf Coast winter storm
National championship win
Judge blocks report release
Acting defense secretary
CBP One app shut down
Elise Stefanik testifies
Discuss strengthening ties
Trailblazing cartoonist dies
Birthright citizenship suit
Can target schools, churches
To host '25 Grammy Awards
Djokovic beats Alcaraz
Antisemitism lawsuits settled
Doug Collins hearing
1st Japanese elected to HOF
Related topics
United States
Blue Monday
Johnson & Johnson
Spravato
Food and Drug Administration
Feedback